CD14 and bone sarcoma: In addition to the TAM markers mentioned above, in a study by Han et al. [62], patients with aggressive pediatric bone sarcomas showed an increased number of peripheral CD14+ HLA-DR low/immunosuppressive monocytes and CTLA-4+ T cells, as well as CD14+ macrophage infiltrates.